Ocimum Bio Buys Gene Logic's Genomic Business For $10 Million

Hyderabad based Ocimum Biosolutions today announced that it has agreed to buy Maryland, US-based Gene Logic's Genomics Business for $10 million in cash. The purchase includes Gene Logic's knowledge products business. They include the genomic database (BioExpress) and other programmes like ToxExpress, Genesis software system and web-enabled products like Ascenta, Sciantis and ToxShield.
As part of the transaction, Ocimum has also acquired Gene Logic's genomic and genetic services business.
Investment bank O3 Capital advised Ocimum on the deal. Ocimum will continue to operate the business out of the current state-of-the-art laboratory facility in Gaithersburg, Maryland. World Bank private equity arm International Finance Corporation had invested $6.5 million in Ocimum last year.

Comments

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.

More information about formatting options



Job By Category

View All

Job By Location

View All
Indepth
Doing Due Diligence Of A Company In "Troubled Waters"
SUJJAIN TALWAR & RAMYA MOHAN, ECONOMIC LAWS PRACTISE
Companies in ‘troubled waters’ normally pay less attention to compliance matters.
What Regulation Applies if No Exemption is Granted?
SAHIL SHAH & VAIDYANATHAN IYER, NISHITH DESAI ASSOCIATES
No convincing argument was made by the promoters to SEBI for obtaining the exemption in the case of Citadel Realty.
Interviews
AIM head brushes aside the shareholder activism dampener as specific to just a few cos & not a wide phenomenon.
Siguler Guff's Praneet Singh says PE Funds need to tighten processes and operations.